UK Stocks-Factors to watch on Sept. 15

    Sept 15 - Britain's FTSE 100 index is seen opening six points higher
at 6,032 on Tuesday, according to financial bookmakers.
    * ASTRAZENECA: AstraZeneca's COVID-19 vaccine trial remains on hold
in the United States pending a U.S. investigation into a serious side effect in
Britain even as other trials of the vaccine resume, sources familiar with the
details told Reuters.
    * G4S: Britain's G4S said on Monday it had rejected a 2.95 billion
pound offer from Canadian security firm GardaWorld, saying it was "highly
    * GOLD: Gold prices rose on Tuesday as the dollar remained subdued, with
investors turning their focus to a U.S. Federal Reserve monetary policy meeting,
seeking details of its plans on inflation targeting.
    * OIL: Oil prices slipped on Tuesday as worries over slow recovery in global
fuel demand were reinforced by warnings by major oil producers, but
short-covering ahead of a meeting later this week of OPEC and its allies, known
as OPEC+, limited losses.
    * The UK blue-chip index shed 0.1% on Monday, as the prospect of
waning demand weighed on heavyweight energy stocks, while security firm G4S
propped up the midcap index after it rejected a takeover from Canadia's
    * UK CORPORATE DIARY:       
 Eve Sleep Plc                    HY results
 Ocado Plc                        Q3 trading statement
 Marshalls Plc                    HY results
 Polypipe Group Plc               HY results
 Jtc Plc                          HY results
    * For more on the factors affecting European stocks, please click on:
    > Financial Times                     
    > Other business headlines            

 (Reporting by Samantha Machado in Bengaluru)